Residual platelet reactivity after aspirin and clopidogrel treatment predicts 2-year major cardiovascular events in patients undergoing percutaneous coronary intervention

European Journal of Internal Medicine

Volumn 22, Issue 5, 2011, Pages 471-477

  Chiu, Fu Chun ^a   Wang, Tzung Dau ^a   Lee, Jen Kuang ^a   Shih, Fuh Yuan ^a   Lin, Jong Wei ^a   Huang, Chien Hua ^a   Chen, Wen Jone ^a   Chen, Ming Fong ^a  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

Anti platelets; Atherothrombosis; Coronary intervention; Platelet

Indexed keywords

ACETYLSALICYLIC ACID; ADENOSINE DIPHOSPHATE; ADRENALIN; CLOPIDOGREL; COLLAGEN;

ACUTE CORONARY SYNDROME; ADULT; AGED; ARTICLE; BRAIN ISCHEMIA; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; DRUG WITHDRAWAL; FEMALE; FOLLOW UP; HEART INFARCTION; HEART MUSCLE REVASCULARIZATION; HOSPITALIZATION; HUMAN; HUMAN CELL; LOADING DRUG DOSE; MAJOR CLINICAL STUDY; MALE; MORTALITY; PERCUTANEOUS CORONARY INTERVENTION; RISK ASSESSMENT; STABLE ANGINA PECTORIS; STROKE; THROMBOCYTE AGGREGATION; UNSTABLE ANGINA PECTORIS;

AGED; ANGIOPLASTY, BALLOON, CORONARY; ASPIRIN; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG THERAPY, COMBINATION; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PLATELET ACTIVATION; PLATELET AGGREGATION INHIBITORS; PREOPERATIVE CARE; PROGNOSIS; RETROSPECTIVE STUDIES; STROKE; SURVIVAL RATE; TAIWAN; TICLOPIDINE; TIME FACTORS;

EID: 80052965507     PISSN: 09536205     EISSN: 18790828     Source Type: Journal    
DOI: 10.1016/j.ejim.2011.02.021     Document Type: Article

References (33)

1. S.R. Mehta, S. Yusuf, R.J. Peters, M.E. Bertrand, B.S. Lewis, and M.K. Natarajan Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study Lancet 358 2001 527 533 (Pubitemid 32772726)
2. S.R. Steinhubl, P.B. Berger, J.T. Mann III, E.T. Fry, A. DeLago, and C. Wilmer Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: a randomized controlled trial JAMA 288 2002 2411 2420 (Pubitemid 35340537)
3. C.M. Moerenhout, M.J. Claeys, S. Haine, H. Miljoen, J.M. Bosmans, and F. Vertessen Clinical relevance of clopidogrel unresponsiveness during elective coronary stenting: experience with the point-of-care platelet function assay-100 C/ADP Am Heart J 159 2010 434 438
4. T. Cuisset, C. Frere, J. Quilici, F. Barbou, P.E. Morange, and T. Hovasse High post-treatment platelet reactivity identified low-responders to dual antiplatelet therapy at increased risk of recurrent cardiovascular events after stenting for acute coronary syndrome J Thromb Haemost 4 2006 542 549
5. D. Trenk, W. Hochholzer, M.F. Fromm, L.E. Chialda, A. Pahl, and C.M. Valina Cytochrome P450 2C19 681G > A polymorphism and high on-clopidogrel platelet reactivity associated with adverse 1-year clinical outcome of elective percutaneous coronary intervention with drug-eluting or bare-metal stents J Am Coll Cardiol 51 2008 1925 1934 (Pubitemid 351636443)
6. G. Campo, M. Valgimigli, A. Frangione, M. Tebaldi, and R. Ferrari Prognostic value of serial platelet reactivity measurements on long-term clinical outcome in patients with ST-elevation myocardial infarction undergoing primary PCI J Thromb Haemost 6 2008 1824 1826
7. P.G. Steg, D.L. Bhatt, P.W. Wilson, R. D'Agostino Sr., E.M. Ohman, and J. Rother One-year cardiovascular event rates in outpatients with atherothrombosis JAMA 297 2007 1197 1206 (Pubitemid 46465728)
8. S. Yusuf, F. Zhao, S.R. Mehta, S. Chrolavicius, G. Tognoni, and K.K. Fox Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation N Engl J Med 345 2001 494 502 (Pubitemid 32758501)
9. P.A. Gurbel, K.P. Bliden, K.M. Hayes, J.A. Yoho, W.R. Herzog, and U.S. Tantry The relation of dosing to clopidogrel responsiveness and the incidence of high post-treatment platelet aggregation in patients undergoing coronary stenting J Am Coll Cardiol 45 2005 1392 1396 (Pubitemid 40615608)
10. J. Gianetti, M.S. Parri, S. Sbrana, F. Paoli, S. Maffei, and U. Paradossi Platelet activation predicts recurrent ischemic events after percutaneous coronary angioplasty: a 6 months prospective study Thromb Res 118 2006 487 493 (Pubitemid 44292804)
11. P.C. Elwood, A. Beswick, J. Pickering, P. McCarron, J.R. O'Brien, and S.R. Renaud Platelet tests in the prediction of myocardial infarction and ischaemic stroke: evidence from the Caerphilly Prospective Study Br J Haematol 113 2001 514 520 (Pubitemid 32523163)
12. T.W. Meade, J.A. Cooper, and G.J. Miller Platelet counts and aggregation measures in the incidence of ischaemic heart disease (IHD) Thromb Haemost 78 1997 926 929 (Pubitemid 27365594)
13. S. Kamath, A.D. Blann, and G.Y. Lip Platelet activation: assessment and quantification Eur Heart J 22 2001 1561 1571 (Pubitemid 32801301)
14. E.J. Favaloro Clinical utility of the PFA-100 Semin Thromb Hemost 34 2008 709 733
15. S. Ziegler, T. Maca, E. Alt, W. Speiser, B. Schneider, and E. Minar Monitoring of antiplatelet therapy with the PFA-100 in peripheral angioplasty patients Platelets 13 2002 493 497 (Pubitemid 35373664)
16. G. Campo, M. Valgimigli, D. Gemmati, G. Percoco, S. Tognazzo, and G. Cicchitelli Value of platelet reactivity in predicting response to treatment and clinical outcome in patients undergoing primary coronary intervention: insights into the STRATEGY Study J Am Coll Cardiol 48 2006 2178 2185 (Pubitemid 44873056)
17. I. Fuchs, M. Frossard, A. Spiel, E. Riedmuller, A.N. Laggner, and B. Jilma Platelet function in patients with acute coronary syndrome (ACS) predicts recurrent ACS J Thromb Haemost 4 2006 2547 2552 (Pubitemid 44741545)
18. J.S. Alpert, K. Thygesen, E. Antman, and J.P. Bassand Myocardial infarction redefined-a consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction J Am Coll Cardiol 36 2000 959 969
19. B. Jilma Platelet function analyzer (PFA-100): a tool to quantify congenital or acquired platelet dysfunction J Lab Clin Med 138 2001 152 163 (Pubitemid 32812228)
20. E.H. Elsenberg, J.W. van Werkum, R.M. van de Wal, A.C. Zomer, H.J. Bouman, and F.W. Verheugt The influence of clinical characteristics, laboratory and inflammatory markers on 'high on-treatment platelet reactivity' as measured with different platelet function tests Thromb Haemost 102 2009 719 727
21. D.E. Cutlip, S. Windecker, R. Mehran, A. Boam, D.J. Cohen, and G.A. van Es Clinical end points in coronary stent trials: a case for standardized definitions Circulation 115 2007 2344 2351 (Pubitemid 46685903)
22. M. Frossard, I. Fuchs, J.M. Leitner, K. Hsieh, M. Vlcek, and H. Losert Platelet function predicts myocardial damage in patients with acute myocardial infarction Circulation 110 2004 1392 1397 (Pubitemid 39238016)
23. A.L. Frelinger III, Y. Li, M.D. Linden, M.R. Barnard, M.L. Fox, and D.J. Christie Association of cyclooxygenase-1-dependent and -independent platelet function assays with adverse clinical outcomes in aspirin-treated patients presenting for cardiac catheterization Circulation 120 2009 2586 2596
24. D.J. Christie, K. Kottke-Marchant, and R.T. Gorman Hypersensitivity of platelets to adenosine diphosphate in patients with stable cardiovascular disease predicts major adverse events despite antiplatelet therapy Platelets 19 2008 104 110 (Pubitemid 351302380)
25. C.P. Hayward, P. Harrison, M. Cattaneo, T.L. Ortel, and A.K. Rao Platelet function analyzer (PFA)-100 closure time in the evaluation of platelet disorders and platelet function J Thromb Haemost 4 2006 312 319
26. M. Crescente, A. Di Castelnuovo, L. Iacoviello, J. Vermylen, C. Cerletti, and G. de Gaetano Response variability to aspirin as assessed by the platelet function analyzer (PFA)-100. A systematic review Thromb Haemost 99 2008 14 26
27. N.J. Breet, J.W. van Werkum, H.J. Bouman, J.C. Kelder, H.J. Ruven, and E.T. Bal Comparison of platelet function tests in predicting clinical outcome in patients undergoing coronary stent implantation JAMA 303 2010 754 762
28. D.L. Bhatt, M.D. Flather, W. Hacke, P.B. Berger, H.R. Black, and W.E. Boden Patients with prior myocardial infarction, stroke, or symptomatic peripheral arterial disease in the CHARISMA trial J Am Coll Cardiol 49 2007 1982 1988 (Pubitemid 46694290)
29. S. Raman, and B. Jilma Time lag in platelet function inhibition by clopidogrel in stroke patients as measured by PFA-100 J Thromb Haemost 2 2004 2278 2279 (Pubitemid 40185799)
30. M. Franchini, and P.M. Mannucci New antiplatelet agents: why they are needed Eur J Intern Med 20 2009 733 738
31. P.M. Mannucci, and M. Franchini New antiplatelet agents in acute coronary syndromes (ACS): an update Eur J Intern Med 21 2010 465 466
32. J.M. Siller-Matula, K. Huber, G. Christ, K. Schror, J. Kubica, and H. Herkner Impact of clopidogrel loading dose on clinical outcome in patients undergoing percutaneous coronary intervention: a systematic review and meta-analysis Heart 97 2011 98 105
33. M.G. Van der Planken, M.J. Claeys, F.J. Vertessen, D. Dilling, J.M. Bosmans, and Z.N. Berneman Comparison of turbidimetric aggregation and in vitro bleeding time (PFA-100) for monitoring the platelet inhibitory profile of antiplatelet agents in patients undergoing stent implantation Thromb Res 111 2003 159 164 (Pubitemid 37532854)